Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

Marco Vitolo, Vincenzo L. Malavasi, Marco Proietti, Igor Diemberger, Laurent Fauchier, Francisco Marin, Michael Nabauer, Tatjana S. Potpara, Gheorghe-Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo Pietro Maggioni, Deirdre A. Lane, Gregory Y.H. Lip, Giuseppe Boriani*, ESC-EHRA EORP-AF Long-Term General Registry Investigators, Albert Marni Joensen (Member of study group), Anders Gammelmark (Member of study group), Lars Hvilsted Rasmussen (Member of study group), Pia Thisted Dinesen (Member of study group)Sam Riahi, Stine Krogh Venø, Birthe Ginnerup Sørensen, Anne Marie Korsgaard, Karen Petrea Andersen , Camilla Fragtrup Hellum

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

1 Citation (Scopus)
Original languageEnglish
JournalEuropean Journal of Internal Medicine
ISSN0953-6205
DOIs
Publication statusPublished - May 2022

Bibliographical note

Copyright © 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Keywords

  • AF registry
  • Atrial fibrillation
  • Biomarkers
  • Death
  • Major adverse cardiovascular events
  • Troponins
  • outcomes

Fingerprint

Dive into the research topics of 'Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry'. Together they form a unique fingerprint.

Cite this